Table 3.
author | year | No. | regimen | response rate | median survival time | 1-year survuval rate |
JL Raoul [13] | 1995 | 24 | radiotherapy + chemotherapy | 65% | - | 47.1% |
H Yamanaka [25] | 1998 | 17 | radiotherapy + CDGP§ + 5-FU# | 76.50% | - | - |
K Nemoto [15] | 2001 | 33 | radiotherapy alone(21) or radiotherapy + CDDP* + 5-FU (12) | - | 7 months | 33% |
Y Nishimura [12] | 2003 | 13 | radiotherapy + CDDP + 5-FU | 72% | 9.5 months | 28% |
H Shimada [14] | 2003 | 76 | chemoradiotheray(47), chemotherapy alone(17), radiotherapy alone(12) | 34% | 8 months | 31% |
K Nemoto [16] | 2003 | 7 | radiotherapy + CDGP + 5-FU | 100% | - | 69% |
* CDDP: cisplatin, § CDGP: nedaplatin, # 5-FU: 5-fluorouracil